Steve Warrington

4.3k citations
106 papers · 2.6k · h-index 30

Impact in

Papers in

  • Pharmacology 13
    • Antibiotics Pharmacokinetics and Efficacy 3
  • Physiology 13
    • Simulation-Based Education in Healthcare 3
Co-authors
Malcolm Boyce (30 shared papers)Kathy Baisley (7 shared papers)Yoichiro Ogama (1 shared paper)Yuichi Sakurai (1 shared paper)Kiyoshi Ashida (1 shared paper)Tomoki Yoneyama (1 shared paper)Helen Jenkins (1 shared paper)Hiroyuki Okamoto (1 shared paper)
Journals
British Journal of Clinical Pharmacology (10 papers)European Journal of Clinical Pharmacology (6 papers)Alimentary Pharmacology & Therapeutics (5 papers)Journal of Cardiovascular Pharmacology (4 papers)The Journal of Clinical Pharmacology (3 papers)
Partner nations
United KingdomUnited StatesJapan

In The Last Decade

Steve Warrington

105 papers receiving 2.4k citations

Peers

Steve Warrington
Comparison fields: 5 of 133
  • Gastroenterology 239
  • Physiology 421
  • Immunology and Allergy 86
  • Hematology 162
  • Pharmacology 233
Replace John J. Herbst with:
John J. Herbst United States
Katherine A. Lyseng‐Williamson New Zealand
Saul J. Karpen United States
Paul L. McCormack New Zealand
Walid M. Awni United States
Norton J. Greenberger United States
Francesco Paolo D’Armiento Italy
Robert Krämer United States
Roberto Testa Italy
A J Levi United Kingdom
Steve Warrington relative to John J. Herbst United States John J. Herbst's profile →
Citations per field
00.5×2×3×4×5×
John J. Herbst · 1×
Citations per year

Countries citing papers authored by Steve Warrington

Since Specialization
Citations

This map shows the geographic impact of Steve Warrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Warrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Warrington more than expected).

Fields of papers citing papers by Steve Warrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Warrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Warrington. The network helps show where Steve Warrington may publish in the future.

Co-authors

The 25 scholars most cited alongside Steve Warrington, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steve Warrington Line = papers co-authored together Steve Warrington links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response
The Lancet ·Shannon A. Bryan, Brian O’Connor, Salah Matti, Margaret J Leckie, Varsha Kanabar, Jamey Khan, Steve Warrington, Louis M. Renzetti, Alexis Rames, Juergen A Bock, Malcolm Boyce, Trevor T. Hansel, Stephen T. Holgate, Peter J. Barnes
2000282
2
Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK‐438 (vonoprazan), a novel potassium‐competitive acid blocker, in healthy male subjects
Alimentary Pharmacology & Therapeutics ·Helen Jenkins, Yuichi Sakurai, Akira Nishimura, Hiroyuki Okamoto, Mark G. Hibberd, Richard O. Jenkins, Tomoki Yoneyama, Kiyoshi Ashida, Yoichiro Ogama, Steve Warrington
2015243
3
Effects of intravenous infusion of prostacyclin (PGI2) in man
Prostaglandins ·John O’Grady, Steve Warrington, M.J. Moti, S Bunting, R.J. Flower, A. S. E. Fowle, E.A. Higgs, Salvador Moncada
198092
4
Pharmacokinetics, Metabolism, and Disposition of Deferasirox in β-Thalassemic Patients with Transfusion-Dependent Iron Overload Who Are at Pharmacokinetic Steady State
Drug Metabolism and Disposition ·Felix Waldmeier, Gerard Bruin, Ulrike Glaenzel, Katharine Hazell, Romain Séchaud, Steve Warrington, John B. Porter
201078
5
Gd-DOTA
Investigative Radiology ·MARIE-MADELEINE LE MIGNON, C. Chambon, Steve Warrington, ROGER DAVIES, Bruno Bonnemain
199077
6
Safety, pharmacokinetics and pharmacodynamics of the anti‐hepcidin Spiegelmer lexaptepid pegol in healthy subjects
British Journal of Pharmacology ·Malcolm Boyce, Steve Warrington, B Cortezi, Stefan Zöllner, S Vauléon, Dorine W. Swinkels, Luciana Summo, Frank Schwoebel, Kai Riecke
201672
7
Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24‐h intragastric pH and serum gastrin in healthy subjects
Alimentary Pharmacology & Therapeutics ·Steve Warrington, Kathy Baisley, Malcolm Boyce, Bina Tejura, Anna Morocutti, Neil Miller
200261
8
Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo‐controlled, double‐blind, crossover study
British Journal of Clinical Pharmacology ·Malcolm Boyce, Kathy Baisley, Steve Warrington
201158
9
Crossover study of the haematological effects and pharmacokinetics of glycosylated and non‐glycosylated G‐CSF in healthy volunteers
British Journal of Haematology ·Michael Watts, Ian E. Addison, S. G. Long, Sigan L. Hartley, Steve Warrington, Malcolm Boyce, David C. Linch
199757
10
The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions
British Journal of Clinical Pharmacology ·Stipo Jurčević, Charles Humfrey, Mohib Uddin, Steve Warrington, Bengt Larsson, Christina Keen
201555
11
Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men
International Journal of Clinical Pharmacology and Therapeutics ·A.-R. van Troostenburg, Elizabeth V. Clark, Wayne Carey, Steve Warrington, William Kerns, Ilan Cohn, Michael H. Silverman, S. Bar‐Yehuda, K L Fong, Pnina Fishman
200455
12
A novel peptide-based pan-influenza A vaccine: A double blind, randomised clinical trial of immunogenicity and safety
Vaccine ·James N. Francis, Campbell Bunce, Claire Horlock, Jeannette M. Watson, Steve Warrington, Bertrand Georges, Carlton B. Brown
201446
13
Tolerability, pharmacokinetics and pharmacodynamics of TA‐8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects
British Journal of Clinical Pharmacology ·J. Ford, Matt Lawson, D. E. Fowler, Nobuko Maruyama, Seiji Mito, Koichi Tomiyasu, Shuji Kinoshita, Chisa Suzuki, Atsuhiro Kawaguchi, Patrick Round, Malcolm Boyce, Steve Warrington, Werner Weber, Sander van Deventer, John J.P. Kastelein
201445
14
A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition
Journal of Neural Transmission ·Anthony Clarke, E S Johnson, Nicholas Mallard, T. H. Corn, A. E. Johnston, Malcolm Boyce, Steve Warrington, Douglas G MacMahon
200345
15
Pharmacokinetics, safety, tolerability and immunogenicity of FKB327, a new biosimilar medicine of adalimumab/Humira, in healthy subjects
British Journal of Clinical Pharmacology ·Adeep Puri, Andrew Niewiarowski, Yasumasa Arai, H Nomura, Mark E. Baird, Isobel Dalrymple, Steve Warrington, Malcolm Boyce
201745
16
Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants
Antimicrobial Agents and Chemotherapy ·Elizabeth G. Rhee, Matthew L. Rizk, Nicole Calder, Marcela Nefliu, Steve Warrington, Michael S. Schwartz, Eric Mangin, Keith Boundy, Pratik Bhagunde, Francheska Colón‐González, Patricia Jumes, Yang Liu, Joan R. Butterton
201844
17
The phytic acid mineral, trace element, protein and moisture content of UK Asian immigrant foods.
Scientiae mathematicae Japonicae ·N. T. Davies, Steve Warrington
198642
18
Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers
Drugs in R&D ·Stephen Pawsey, Mike Wood, Helen Browne, Kirsteen Donaldson, Mark Christie, Steve Warrington
201641
19
A five way crossover human volunteer study to compare the pharmacokinetics of paracetamol following oral administration of two commercially available paracetamol tablets and three development tablets containing paracetamol in combination with sodium bicarbonate or calcium carbonate
European Journal of Pharmaceutics and Biopharmaceutics ·T. J. Grattan, Rachel Hickman, Anne Darby-Dowman, Marshall A. Hayward, Malcolm Boyce, Steve Warrington
200041
20
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of Taranabant, a Novel Selective Cannabinoid‐1 Receptor Inverse Agonist, for the Treatment of Obesity: Results From a Double‐Blind, Placebo‐Controlled, Single Oral Dose Study in Healthy Volunteers
The Journal of Clinical Pharmacology ·Carol Addy, Susie Li, Nancy Agrawal, Julie A. Stone, Anup Majumdar, L. Zhong, Hankun Li, Jinyu Yuan, Andrea Maes, Paul Rothenberg, Josée Côté, Kim Rosko, Corinne E Cummings, Steve Warrington, Malcolm Boyce, Keith Gottesdiener, Aubrey Stoch, John A. Wagner
200839

About Steve Warrington

Steve Warrington is a scholar working on Pharmacology, Physiology, Surgery, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine, having authored 106 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (5 papers), Analytical Methods in Pharmaceuticals (5 papers), Ethics in Clinical Research (4 papers), Gastroesophageal reflux and treatments (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Innovations in Medical Education (4 papers), Simulation-Based Education in Healthcare (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Gastroenterology (239 citations), Physiology (421 citations), Immunology and Allergy (86 citations), Hematology (162 citations) and Pharmacology (233 citations). Steve Warrington has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Malcolm Boyce, Kathy Baisley, Yoichiro Ogama, Yuichi Sakurai, Kiyoshi Ashida, Tomoki Yoneyama, Helen Jenkins, Hiroyuki Okamoto, Akira Nishimura and Richard O. Jenkins. Their work appears in journals such as British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, Alimentary Pharmacology & Therapeutics, Journal of Cardiovascular Pharmacology and The Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John J. HerbstBreakdown of academic impact, for papers by Katherine A. Lyseng‐WilliamsonBreakdown of academic impact, for papers by Saul J. KarpenBreakdown of academic impact, for papers by Paul L. McCormackBreakdown of academic impact, for papers by Walid M. AwniBreakdown of academic impact, for papers by Norton J. GreenbergerBreakdown of academic impact, for papers by Francesco Paolo D’ArmientoBreakdown of academic impact, for papers by Robert KrämerBreakdown of academic impact, for papers by Roberto TestaBreakdown of academic impact, for papers by A J Levi